Thura, M., Al-Aidaroos, A. Q., Gupta, A., Chee, C. E., Lee, S. C., Hui, K. M., . . . Zeng, Q. (2019). PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein. Nat Commun.
Chicago Style CitationThura, Min, et al. "PRL3-zumab As an Immunotherapy to Inhibit Tumors Expressing PRL3 Oncoprotein." Nat Commun 2019.
MLA CitationThura, Min, et al. "PRL3-zumab As an Immunotherapy to Inhibit Tumors Expressing PRL3 Oncoprotein." Nat Commun 2019.
Warning: These citations may not always be 100% accurate.